Er protein regulators and use thereof
AssigneeShanghaitech University
InventorsXiaobao Yang, Biao Jiang, Renhong Sun, Chaowei Ren, Ning Sun, Xing Qiu
Life of this patent
Estimating the term…
Loading patent…
AssigneeShanghaitech University
InventorsXiaobao Yang, Biao Jiang, Renhong Sun, Chaowei Ren, Ning Sun, Xing Qiu
Estimating the term…
The present disclosure relates to an ER protein regulator compound represented by formula (I) and use thereof. LIN in the compound represented by formula (I) is a linker; ULM is a small-molecule ligand of VHL or CRBN protease having a ubiquitylation function; and group X is CH2, O or NH, and group X is covalently linked to ULM by means of the linker LIN. The designed and synthesized compounds of the present disclosure have wide pharmacological activity, has the function of regulating ER protein and inhibiting the activity of tumors, and can be used for preventing and/or treating diseases and disorders associated with estrogen receptors, or related tumor treatment.
A compound of formula (I)
-7. (canceled)
-25. (canceled)
The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, or polymorph thereof of cclaim 26, wherein the LIN represents:
(canceled)
The compound of formula (I) or a salt, enantiomer, stereoisomer, solvate, or polymorph thereof of cclaim 30, wherein the LIN represents:
-44. (canceled)
(canceled)
-65. (cnceled)
Dependencies are inferred from the claim text.